laitimes

Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024

author:TechNode

编辑&整理|Steven Lee

Typesetting|Guo Jinwen

Focusing on the development of sustainable development, life sciences, consumer technology, and technology going overseas, TechNode now publishes the Dynamic Evening News every day to collect and sort out global industry information, hoping to pay attention to the development of global scientific and technological innovation with you and look forward to the new trend of industrial development!

Consumer technology

Meta still plans to work with Tencent to bring the low-cost version of the Quest 3 to China in the fourth quarter According to The Information, Meta still plans to bring the upcoming low-cost version of the Quest 3 to the Chinese market through cooperation with Tencent. According to the report, the structure of the partnership is that Tencent will sell Quest headsets in China and provide technical support, while the two parties will cooperate in the localization and translation of Quest Store content. Meta will receive the majority of the device revenue, while Tencent will receive the majority of the content revenue. This isn't Tencent's first such collaboration, as the company has already sold the Nintendo Switch in the Chinese market. Elon Musk: Humanoid robots cost less than half of cars Tesla CEO Elon Musk recently said that the cost of building a humanoid robot Optimus is only half of Tesla's electric car. Musk said on the social platform, "Although the humanoid robot is more complex per unit mass, I think the final manufacturing cost will still be less than half of Tesla's car." Musk's remarks were a response to Sam Korus, head of autonomous driving and robotics research at ARK Invest, who believes that the barriers to mass production of humanoid robots compared to cars are primarily software capabilities, not manufacturing itself.

Sony will end after-sales support for the PSV and PlayStation Classic on April 25

According to the official news of Sony Interactive Entertainment, from April 25, 2024, it will no longer provide after-sales service for Sony PSV and PlayStation Classic game consoles. Affected PSV products include PCH-1100 series, PCH-1000 series, and PCH-2000 series, and affected PSC products include: SCPH-1000RJ series. Tesla intends to build "private 5G" services: ensure lower latency and faster network speeds to support electric vehicles and humanoid robotsPat Ruelke, principal engineer of IT manufacturing solutions engineering at Tesla, LinkedIn shows that Tesla is developing "private 5G" infrastructure to provide connectivity between its electric vehicles and Optimus humanoid robots. He said Tesla is looking for a cellular system integration engineer to provide a stronger connectivity solution for all Tesla models and the Optimus Prime robot. This position involves understanding internal customer needs, planning and executing test procedures, seamlessly and reliably integrating the eSIM into Tesla's private 5G network infrastructure.

sustainable development

Volvo officially discontinued the production of diesel-engine vehicles and fully shifted to electrification

Swedish automaker Volvo has officially discontinued production of diesel-powered cars, marking an acceleration of its journey to become an all-electric brand by 2030. On March 26, the last Volvo diesel car, a blue XC90 SUV with a 2.0-liter turbocharged engine, rolled off the assembly line at the Torslanda plant in Sweden. The car will be on display at the new Volvo Museum, which will open on April 14, as a testament to history. It also marked the end of Volvo's 45-year relationship with diesel engines and made Volvo the first major traditional car manufacturer to do away with diesel power altogether. Volvo plans to electrify all of its models by 2030, and its factories will be retrofitted to accommodate electric vehicles and battery packs. Back at last year's New York Climate Week event, Volvo announced that it would stop the production of diesel powertrains in 2024.

The world's first ultra-fast charging solid-state battery, the Zhiji L6, will be officially launched in May

The Zhiji L6, the industry's first mass-produced ultra-fast charging solid-state battery, was officially launched in May, leading new energy vehicles into the "solid-state battery era". The ultra-130kWh ultra-fast charging solid-state battery of Zhiji L6 will be coated with ultra-high nickel material with a patented nano-scale solid electrolyte for the positive electrode, and the negative electrode will be a new generation of high-specific energy composite silicon carbon material. Through high-tech materials and processes, the energy density of the battery is greatly improved, and the ultra-long range performance of the vehicle is empowered. Equipped with an ultra-fast charging solid-state battery, the Zhiji L6 has a CLTC range of more than 1,000 km.

Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024

Elephant Motors released its first product: the ZM6 smart electric light truck

Elephant Motors is a global new energy commercial vehicle brand originating from Japan, and a wholly-owned subsidiary of Elephant Future Group, a company listed on the main board of Hong Kong, mainly engaged in the research and development, manufacturing and sales of new energy commercial vehicles. The ZM 6 released this time is Elephant Motors' first intelligent new energy light truck product. The ZM6 has a maximum driving range of 243 km in accordance with the standards specified by the Ministry of Land, Infrastructure, Transport and Tourism of Japan. The ZM 6 uses CATL's high-end battery technology and state-of-the-art liquid cooling system, with a battery pack capacity of 81kwh.

Danfoss Drives launched the iC2-Micro power expansion product, focusing on green transformation and equipment going overseas

Danfoss Drives announced the launch of its iC2-Micro compact inverter power expansion products, including three-phase 400V 18.5kW and 22kW models, three-phase 200V 0.37-3.7kW models, and single-phase 100V 0.37kW and 1.1kW models, making the iC2-Micro compact inverter product line increasingly complete and achieve full power coverage. The entire Danfoss Drives iC2-Micro compact drive complies with the latest UL standard 61800-5-1 and also meets the requirements of UL/IEC 60335-2-40 and CSA C22.2 No. 0335-2-40 22.116 for arcing and sparking of electrical components. Therefore, the iC2-Micro inverter can not only be used safely with low-GWP flammable refrigerants, but also help customers simplify the overall equipment certification process, shorten the testing time and related testing costs, enhance the competitiveness of equipment in the international market, and accelerate the expansion and implementation of overseas business.

Life Sciences

The first human transplant of pig liver was completed in China

According to Xijing Hospital, on March 10, under the leadership of Academician Dou Kefeng of the Chinese Academy of Sciences and Director of the Department of Hepatobiliary Surgery Tao Kaishan, a major breakthrough was made in the clinical research of xenotransplantation in Xijing Hospital of the Air Force Military Medical University: the whole liver of a multi-gene edited pig was successfully transplanted into a brain-dead patient in an adjuvant way. During the operation, the transplanted liver secreted bile immediately after restoring blood flow, and there was no hyperacute rejection, and it continued to work for more than 96 hours. According to reports, the study explored the feasibility of "gene-edited pig-human" liver xenotransplantation for the first time, and made original breakthroughs in scientific theory innovation, core technology research, military medical application, etc., and will play an irreplaceable role in treatment and repair, functional reconstruction, transplantation and replacement, especially in the transplantation of important organs.

Zhiyi Biotech completed the first phase of Series C financing of nearly 100 million yuan to accelerate the advancement of the clinical phase III pipeline

Recently, Guangzhou Zhiyi Biotech completed the first phase of the C round of financing of nearly 100 million yuan, led by Yueke Financial and followed by iResearch. The funds are mainly used for the clinical development of the company's new drug pipeline, especially the phase III clinical trial of SK08. Zhiyi Biotech is a China-based, global original innovative drug R&D company in the clinical development stage, with a complete technology and industrialization platform from strain discovery to LBP development. The company's self-developed SK08 uses a new generation of probiotics, which is the fastest progressing LBP drug in China, and a phase III clinical study for IBS-D (diarrheal irritable bowel syndrome) is underway. Another original variety SK10 for chemotherapy-associated diarrhea is about to complete phase I clinical trials in the United States.

诺和诺德收购Cardior Pharmaceuticals,强化心血管疾病研发管线

Novo Nordisk and Cardior Pharmaceuticals recently announced that Novo Nordisk has agreed to acquire Cardior for up to €1.025 billion, including upfront payments and additional payments following the achievement of certain R&D and commercial milestones. The agreement includes a CDR132L of Cardior's lead compound, which is currently in Phase 2 clinical development for heart failure.

Innovent completed the first patient in the neoadjuvant Phase III clinical study (Neoshot) of IBI310 (anti-CTLA-4 monoclonal antibody) in colon cancer

Innovent Biologics announced that the first patient in China has completed the first randomized, controlled, multicenter Phase III clinical study (Neoshot) of IBI310 (anti-CTLA-4 monoclonal antibody) in combination with sintilimab (PD-1 inhibitor) in patients with resectable microsatellite high instability or mismatch repair protein deficiency (MSI-H/dMMR) colon cancer (stage cT4 or cN+) in China.

The domestic nine-valent HPV vaccine is expected to be launched in 2024, and the market pattern may change

The domestic nine-valent HPV vaccine is expected to be launched this year, and Wantai Biotech has completed the clinical trial stage and is waiting for review and approval. If approved, the market landscape will change and challenge the exclusive position of foreign company Merck. Other companies, such as Kangle Guard, are also actively promoting the research and development of the 9-valent HPV vaccine.

Science and technology go to sea

The Xpeng G9 / P7 models are available in Germany with prices starting at 49,600 euros

On March 27, local time, Xpeng Motors announced that it had officially entered the German market and would begin selling the international versions of the Xpeng G9 and Xpeng P7 in Germany in May this year. According to the latest plan, Xpeng Motors will adopt a dealer model for sales in Germany, and after the start of sales in May, Xpeng Motors will cooperate with 12 local high-quality dealers to operate in 24 retail locations in Germany, with the goal of increasing the number of dealerships to 60 and expanding to 120 retail locations by the end of 2026. In the future, Xpeng will also enter other European markets, including France, Italy and the United Kingdom.

Qoala, an Indonesian insurtech company, has raised $47 million in Series C funding

Indonesian insurtech startup Qoala has recently announced the closing of its $47 million Series C funding round. It is understood that the financing was co-led by PayPal Ventures and MassMutual Ventures, with participation from MUFG Innovation Partners, Ohana Holdings and its existing investors Flourish Ventures, Eurazeo and AppWorks. According to the statement, the funds will be used to advance Qoala's expansion in Southeast Asia, develop new products and channels, and explore strategic acquisitions and partnerships within verticals. To date, Qoala has raised more than $130 million in funding.

Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024

data.ai: LINE Manga joins the $2 billion mobile consumer spend club

According to a report released by data.ai, three years after global consumer spend surpassed $1 billion, LINE Manga has reached its second billion dollar level, becoming the 15th non-gaming app to achieve this milestone. What's even more surprising is that this is the second app from the publisher to step into the $2 billion club, after its flagship messaging app of the same name, LINE. Google is currently the only other company with multiple $2 billion in revenue-level apps (YouTube and Google One).

See: https://cn.technode.com/post/2024-03-28/data-ai-line-manga/

Geek+ and Ferag announce a partnership for supply and integration in the Asia Pacific region

Geekplus, a company in mobile robotics and smart logistics solutions, has announced a partnership with Ferag in the Asia Pacific region. This partnership enables Ferag APAC to supply, install and service Geekplus equipment, thus becoming an integrated solutions provider in the Asia-Pacific region. The strategic alliance combines Geekplus' cutting-edge "goods-to-person" suite of mobile robot solutions with Ferag's system integration expertise and advanced warehouse software to provide customers in the Asia-Pacific region with integrated warehouse systems.

Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024

One-click forwarding, poke and watch!

Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024
Musk: The cost of humanoid robots is less than half of that of cars, and the domestic nine-valent HPV vaccine is expected to be launched in 2024

Read on